A detailed history of Al Ti Global, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Al Ti Global, Inc. holds 4,091 shares of BMY stock, worth $228,400. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,091
Previous 164,335 97.51%
Holding current value
$228,400
Previous $8.5 Billion 97.28%
% of portfolio
0.01%
Previous 0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$51.92 - $59.94 $8.32 Million - $9.61 Million
-160,244 Reduced 97.51%
4,091 $231 Million
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $2.26 Million - $2.95 Million
57,067 Added 53.2%
164,335 $8.5 Billion
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $3.84 Million - $5.05 Million
95,291 Added 795.62%
107,268 $4.45 Billion
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $105,220 - $119,299
2,193 Added 22.41%
11,977 $650 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $474,328 - $566,004
9,784 New
9,784 $502 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Al Ti Global, Inc. Portfolio

Follow Al Ti Global, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Al Ti Global, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Al Ti Global, Inc. with notifications on news.